Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers
To access this article, please choose from the options below
PII: S0306-9877(04)00637-1
doi:10.1016/j.mehy.2004.09.026
© 2004 Elsevier Ltd. All rights reserved.
